Systemic vascular effects of thrombin and thrombin receptor activating peptide in rats

被引:11
|
作者
Sicker, T [1 ]
Wuchold, F [1 ]
Kaiser, B [1 ]
Glusa, E [1 ]
机构
[1] Univ Jena, Fac Med, Ctr Vasc Biol & Med, Unit Expt Angiol, D-99089 Erfurt, Germany
关键词
thrombin; TRAP; vascular effects; blood pressure;
D O I
10.1016/S0049-3848(00)00429-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The proteolytic enzyme thrombin activates its receptor by cleavage of a peptide from the extracellular N-terminus. The newly generated N-terminus acts as a tethered ligand to activate the receptor. Receptor-mediated cellular effects of thrombin can be mimicked by synthetic peptides, which correspond to the amino acid sequence of the newly formed N-terminus. The aim of the present study was to investigate vascular effects of thrombin and the thrombin receptor activating peptide (TRAP: SFLLRN) in vitro and in vivo in rats. In precontracted rat aortic rings, both thrombin (0.3, 1, 3 U/ml) and TRAP (1, 3, 10, 20, 40 muM) induced endothelium-dependent relaxant responses. In anaesthetized rats, the mean arterial blood pressure (MAP) was measured continuously in the carotid artery by a pressure transducer. Thrombin and TRAP were administered as intravenous bolus injection via the femoral vein. Thrombin at doses of 3-100 U/kg, as well as TRAP at doses of 0.1 -0.6 mg/ kg iv, caused a reversible decrease in MAP. Administration of TRAP at doses of 0.3 and 0.6 mg/kg led to a triphasic response in most of the animals treated (50% and 75%, respectively), i.e. a short drop of MAP was followed by an increase and finally a longer lasting decrease in MAP. Pretreatment with the nitric oxide (NO)-synthase inhibitor N-G-nitro-L-arginine-methylester (L-NAME) suppressed the dose-dependent vasodilator effects of thrombin. Heparin and hirudin also inhibited the hypotensive response to thrombin. The TRAP-induced triphasic reaction on MAP was not affected by the serotonin antagonists ketanserin and tropisetron, as well as the aminopeptidase inhibitor amastatin. Pretreatment with L-NAME led to an inhibition of hypotension induced by TRAP at 0.1 mg/kg, as well as of the initial transient fall in blood pressure at doses of 0.3 and 0.6 mg/kg. The studies suggest that the thrombin- and TRAP-induced vasodilation in vitro and in vivo is in part due to the release of endothelial NO. In the blood pressure response to TRAP, additional effects seem to be involved. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:467 / 475
页数:9
相关论文
共 50 条
  • [41] ACTIONS OF THROMBIN RECEPTOR PEPTIDE ANALOGS IN VASCULAR AND GASTRIC TISSUE - EVIDENCE FOR RECEPTOR SUBTYPES
    LANIYONU, A
    SAIFEDDINE, M
    MOORE, GJ
    HOLLENBERG, MD
    CLINICAL RESEARCH, 1993, 41 (02): : A148 - A148
  • [42] CORONARY VASCULAR EFFECTS OF THROMBIN RECEPTOR AGONIST AND ANTAGONIST PEPTIDES
    KU, DD
    ZALESKI, JK
    PALGUNACHARI, MN
    FASEB JOURNAL, 1994, 8 (04): : A328 - A328
  • [43] Direct vascular effects of thrombin receptor activation in vivo in man
    Gudmundsdottir, I.
    Ludlam, C.
    Webb, D.
    Fox, K.
    Newby, D.
    HEART, 2007, 93 : A2 - A3
  • [44] The Ca2+-mobilizing potency of alpha-thrombin and thrombin-receptor-activating peptide on human platelets - Concentration and time effects of thrombin-induced Ca2+ signaling
    Heemskerk, JWM
    Feijge, MAH
    Henneman, L
    Rosing, J
    Hemker, HC
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 249 (02): : 547 - 555
  • [45] Relaxant and contractile responses of porcine pulmonary arteries to thrombin and thrombin receptor activating peptides
    Glusa, E
    Paintz, M
    Bretschneider, E
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1996, 22 (03): : 261 - 265
  • [46] THROMBIN RECEPTOR-ACTIVATING PEPTIDE PROMOTES PROLIFERATION OF CULTURED HUMAN CORNEAL EPITHELIUM
    HALLBERG, C
    RAMAKRISHRAN, S
    CARNEY, DH
    BRYSK, MM
    TROCME, SD
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1993, 34 (04) : 1011 - 1011
  • [47] Thrombin receptor activating peptide (SFLLRN) potentiates shear-induced platelet microvesiculation
    Chow, TW
    Hellums, JD
    Thiagarajan, P
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2000, 135 (01): : 66 - 72
  • [48] THE THROMBIN RECEPTOR ACTIVATING PEPTIDE (TRAP) DOES NOT STIMULATE PLATELET PROCOAGULANT ACTIVITY (PPA)
    GOODWIN, C
    SCULLY, MF
    KAKKAN, VV
    WHEELERJONES, CPD
    PATEL, G
    AUTHI, KS
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 696 - 696
  • [49] Recombinant apolipoprotein(a) and lipoprotein(a) enhance platelet responses to a thrombin receptor-activating peptide
    Koschinsky, ML
    Sangrar, W
    Marcovina, SM
    Taylor, DM
    Packham, MA
    Rand, ML
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 143 - 143
  • [50] DEGRANULATION OF HUMAN PLATELETS BY THE THROMBIN RECEPTOR PEPTIDE SFLLRN - COMPARISON WITH DEGRANULATION BY THROMBIN
    KINLOUGHRATHBONE, RL
    PERRY, DW
    GUCCIONE, MA
    RAND, ML
    PACKHAM, MA
    THROMBOSIS AND HAEMOSTASIS, 1993, 70 (06) : 1019 - 1023